Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01193465
Other study ID # humidity
Secondary ID
Status Recruiting
Phase Phase 4
First received August 30, 2010
Last updated September 1, 2010
Start date January 2010
Est. completion date October 2010

Study information

Verified date July 2010
Source Korea University Anam Hospital
Contact Seung Zhoo Yoon, Assist. P.
Phone 082-920-5632
Email monday1031@yahoo.co.kr
Is FDA regulated No
Health authority Korea: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The effects of preserving humidity and temperature by low flow anesthesia are different in each other anesthesia workstation.


Description:

The fresh gas flow(FGF) is dry and cold in old fashioned anesthesia machine, especially at high folw (above 1 L/min). To the contrary, it has been assumed that the heat and humidity of FGF may be preserved using low FGF (below 1 L/min) during anesthesia or new anesthesia work station. However, it has not been proved yet. We hypothesized that the heat and moisture of FGF may be different in various FGF rate during anesthesia. In addition, it may be different in accordance to anesthesia work station. Therefore, we planed prospective observational study that will demonstrate that the difference of heat and moisture of FGF in different anesthesia work station (Excel; 1st generation anesthesia machine of Datex-Ohmeda Corp., Avance; 2nd generation anesthesia work station of Datex-Ohmeda Corp., Cato; 2nd generation generation anesthesia work station of Drager, Primus; 3rd generation generation anesthesia work station of Drager) and different FGF (0.5, 1, 4 L/min)


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date October 2010
Est. primary completion date September 2010
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- patients who planned more than 2 hour operation under general anesthesia

- ASA class 1,2

- blood loss less than 500ml

Exclusion Criteria:

- acute/chronic cardiac or respiratory disease

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research


Related Conditions & MeSH terms


Intervention

Device:
Datex Ohmeda excel anesthesia machine
maintain one of following fresh gas flow, 1 or 4 L/min (nitrous oxide:oxygen =1:1) during 2 hour with using Datex Ohmeda excel anesthesia machine after draping complete
Datex Ohmeda Avance anesthesia work-station
maintain one of following fresh gas flow, 0.5 or 1 or 4 L/min (nitrous oxide:oxygen =1:1) during 2 hour with using Datex Ohmeda Avance anesthesia machine after draping complete
Drager Cato anesthesia work-station
maintain one of following fresh gas flow, 0.5 or 1 or 4 L/min (nitrous oxide:oxygen =1:1) during 2 hour with using Drager Cato anesthesia work-station after draping complete
Drager Primus anesthesia work-station
maintain one of following fresh gas flow, 0.5 or 1 or 4 L/min (nitrous oxide:oxygen =1:1) during 2 hour with using Drager Primus anesthesia work-station after draping complete

Locations

Country Name City State
Korea, Republic of Korea University Anam Hospital Seoul

Sponsors (1)

Lead Sponsor Collaborator
Korea University Anam Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary absolute humidity at both limb of breathing circuit just distal portion of Y-piece time point 1; base line value (fresh gas flow(FGF); 8L/min) time point 2; 5 mintues(min) after FGF change to predetermined level time point 3; 10 min after FGF change to predetermined level time point 4; 15 min after FGF change to predetermined level time point 5; 30 min after FGF change to predetermined level time point 6; 45 min after FGF change to predetermined level time point 7; 60 min time point 8; 75 min time point 9; 90 min time point 10; 105 min time point 11; 120 min time point 1-11 No
Secondary patient body temperature(BT) measure BT using esophageal temperature probe each time points are same as primary outcome time point 1 -11 No
Secondary temperature at both limb of breathing circuit just distal portion of Y-piece the time points are same as primary outcome time point 1- 11 No
See also
  Status Clinical Trial Phase
Recruiting NCT03745079 - Correlation Between Core Temperature and Skin Temperature Measured by 3M SpotOn
Not yet recruiting NCT03649386 - Heated Circuit for One-lung Ventilation N/A
Withdrawn NCT00730119 - Evaluation Of The GE Monitor Product Line N/A
Not yet recruiting NCT05915234 - Effect of Cryotherapy Modalities on Skin Temperature, Radial Artery Size and Flow Where Arterial Puncture Are Performed N/A
Not yet recruiting NCT05886153 - Verification Protocol for the Cloud DX Vitaliti Continuous Vital Signs Monitor (VERDICT-2) N/A
Completed NCT03614780 - Pre Post Evaluation of Temperature, Steps, and Glucose With Additional Time Spent Outdoors in an Urban and Rural Setting N/A
Completed NCT01454882 - Measuring Free-living Energy Expenditure Using Direct Calorimetry N/A
Completed NCT04249479 - Contrast Media Temperature and Patient Comfort in CT of the Abdomen N/A
Recruiting NCT05268848 - Thermography of the Foot With Plantar Orthosis Liners N/A
Active, not recruiting NCT03264833 - Accuracy and Precision Comparison of Temptraq N/A
Not yet recruiting NCT06380582 - Indoor Air Quality, Temperature and Cognitive Performance N/A
Completed NCT01670760 - Zero Heat Flux Thermometry System Comparison Trial N/A
Completed NCT03659474 - Different Cryotherapy Techniques for Skin Surface Temperature, Agility and Balance of Active Youth N/A